A Phase II Study of Hypofractionated Stereotactic Radiotherapy in the Treatment of Metastatic Pediatric Sarcomas of Bony Sites
Johns Hopkins Kimmel Cancer Center in Baltimore
Sibley Memorial Hospital
This research is being done to learn if stereotactic body radiation (SBRT) can effectively treat pediatric sarcomas that have spread to the bone and cannot be removed with surgery. Stereotactic radiation is a very focused and precise type of radiation. A higher dose of radiation is given at every treatment over a fewer number of days than standard radiation treatment. Standard radiation delivers less dose of radiation every day over a longer period of time and is delivered with a different technique that generally treats a larger area in the body. We know that stereotactic radiation can stop sarcomas from growing in adults. This study is being performed to learn if this type of radiation can also stop pediatric sarcomas from growing. With stereotactic radiation, we hope to increase the radiation dose to the tumor and decrease the amount of area treated with radiation.
- People with pediatric sarcoma that has spread to the bone may join - Patients must be greater than 3 years of age and less than or equal to 40 years of age
All patients will recieve 5 doses of radiation over a 5-day period. Patients will then be followed for 3 years.
09/19/2017 05:03 AM